Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
The Journal of Nutrition
|
March 1, 1985
Influence of iron on in vivo proliferation and lethality of L1210 cells
R J Bergeron, R R Streiff, G T Elliott
Journal of Cardiovascular Pharmacology
|
March 10, 2000
Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis?
K Przyklenk, K Hata, P Whittaker, et al.
American Journal of Hospital Pharmacy
|
November 1, 1981
Interest among Florida hospital pharmacists in microwave thawing of frozen intravenous medications
G T Elliott, M P Pevonka, S L Quinn
Journal of Cardiovascular Pharmacology
|
August 13, 1998
Antiischemic effect of monophosphoryl lipid A in conscious rabbits with hypercholesterolemia and atherosclerosis
Z Szilvássy, P Ferdinandy, C W Cluff, et al.
The American Journal of Physiology
|
September 1, 1996
Cardioprotection with ischemic preconditioning and MLA: role of adenosine-regulating enzymes?
K Przyklenk, L Zhao, R A Kloner, et al.
Circulation
|
June 29, 1999
Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel
K Stambaugh, G T Elliott, K A Jacobson, et al.
Journal of Molecular and Cellular Cardiology
|
January 1, 1996
Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA)
L Zhao, C C Kirsch, S R Hagen, et al.
Cardiovascular Research
|
December 1, 1996
Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide
G T Elliott, M L Comerford, J R Smith, et al.
Drugs Under Experimental and Clinical Research
|
November 24, 1998
Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia
N Maulik, A Tosaki, G T Elliott, et al.
Seminars in Surgical Oncology
|
May 1, 1993
Interim results of a phase II multicenter clinical trial evaluating the activity of a therapeutic allogeneic melanoma vaccine (theraccine) in the treatment of disseminated malignant melanoma
G T Elliott, R A McLeod, J Perez, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
The Journal of Nutrition
|
March 1, 1985
Influence of iron on in vivo proliferation and lethality of L1210 cells
R J Bergeron, R R Streiff, G T Elliott
Journal of Cardiovascular Pharmacology
|
March 10, 2000
Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis?
K Przyklenk, K Hata, P Whittaker, et al.
American Journal of Hospital Pharmacy
|
November 1, 1981
Interest among Florida hospital pharmacists in microwave thawing of frozen intravenous medications
G T Elliott, M P Pevonka, S L Quinn
Journal of Cardiovascular Pharmacology
|
August 13, 1998
Antiischemic effect of monophosphoryl lipid A in conscious rabbits with hypercholesterolemia and atherosclerosis
Z Szilvássy, P Ferdinandy, C W Cluff, et al.
The American Journal of Physiology
|
September 1, 1996
Cardioprotection with ischemic preconditioning and MLA: role of adenosine-regulating enzymes?
K Przyklenk, L Zhao, R A Kloner, et al.
Circulation
|
June 29, 1999
Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel
K Stambaugh, G T Elliott, K A Jacobson, et al.
Journal of Molecular and Cellular Cardiology
|
January 1, 1996
Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA)
L Zhao, C C Kirsch, S R Hagen, et al.
Cardiovascular Research
|
December 1, 1996
Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide
G T Elliott, M L Comerford, J R Smith, et al.
Drugs Under Experimental and Clinical Research
|
November 24, 1998
Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia
N Maulik, A Tosaki, G T Elliott, et al.
Seminars in Surgical Oncology
|
May 1, 1993
Interim results of a phase II multicenter clinical trial evaluating the activity of a therapeutic allogeneic melanoma vaccine (theraccine) in the treatment of disseminated malignant melanoma
G T Elliott, R A McLeod, J Perez, et al.
Page
of 4